Business Context and Reporting Period
This Form 8-K was filed by Intelligent Bio Solutions Inc. (INBS) on January 2, 2024, regarding a notice from The Nasdaq Stock Market LLC. The filing addresses the Company's compliance status with Nasdaq Listing Rule 5550(b)(1) concerning minimum stockholders' equity requirements for continued listing on the Nasdaq Capital Market.
Key Financial Metrics
- Stockholders' Equity (Sept 30, 2023): $1,236,558 (reported in Form 10-Q; below the $2,500,000 requirement).
- Stockholders' Equity (Oct 31, 2023 Pro Forma): $4,240,629 (based on a balance sheet submitted to Nasdaq).
- Primary Driver of Equity Increase: A public offering of securities that closed on October 4, 2023.
- Alternative Compliance Metrics: As of November 15, 2023, the Company did not meet the alternative requirements of $35 million market value of listed securities or $500,000 net income from continuing operations.
Material Changes
The Company successfully addressed a deficiency in stockholders' equity that was previously reported in November 2023. The equity position improved from $1,236,558 as of September 30, 2023, to a pro forma $4,240,629 as of October 31, 2023, primarily due to capital raised through a public offering. Consequently, Nasdaq staff determined the Company currently complies with the minimum stockholders' equity requirement.
Outlook, Risks, and Contingencies
While Nasdaq has acknowledged current compliance based on the December 8-K filing, the Company faces a contingency regarding future reporting. Nasdaq warned that if the Company fails to evidence compliance upon filing its Form 10-Q for the period ended December 31, 2023, it may be subject to delisting. The filing does not provide specific revenue, profit, or cash flow guidance beyond the equity figures mentioned.
Investor Verification Checklist
- Verify the final stockholders' equity figure in the upcoming Form 10-Q for the period ended December 31, 2023, to ensure continued listing status.
- Confirm the details and closing status of the public offering that occurred on October 4, 2023.
- Monitor for any further correspondence from Nasdaq regarding the alternative compliance metrics (market value or net income).